Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service

Emergency Medicine Journal

Volumn 28, Issue 8, 2011, Pages 686-689

  James, D ^a   Adams, R D ^b   Spears, R ^c   Cooper, G ^c   Lupton, D J ^b   Thompson, J P ^c   Thomas, S H L ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE; AMINOKETONE; BUTYLONE; COCAINE; ETHYLONE; METHAMPHETAMINE; METHCATHINONE; METHEDRONE; METHELENEDIOXY METHAMFETAMINE; METHYLENEDIOXY PYROVALERONE; METHYLONE; UNCLASSIFIED DRUG;

AGGRESSION; AGITATION; ARTICLE; CONFUSION; CONVULSION; DATA BASE; DRUG INTOXICATION; HEADACHE; HEALTH SERVICE; HEART ARREST; HEART PALPITATION; HUMAN; MEDICAL INFORMATION; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; TACHYCARDIA; THORAX PAIN; UNITED KINGDOM; VASOCONSTRICTION;

CENTRAL NERVOUS SYSTEM STIMULANTS; GREAT BRITAIN; HUMANS; METHAMPHETAMINE; POISON CONTROL CENTERS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 79960773236     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2010.096636     Document Type: Article

References (21)

1. Advisory Council on the Misuse of Drugs. Consideration of the cathinones. 31 Mar 2010. http://drugs.homeoffice.gov.uk/publication-search/acmd/ACMD- cathinones-report. html (accessed 1 Apr 2010).
2. Winstock AR, Marsden J, Mitcheson L. What should be done about mephedrone? BMJ 2010;340:c1605.
3. Kamata HT, Shima N, Zaitsu K, et al. Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 2006;36:709-23. (Pubitemid 44195985)
4. Markus R, Meyer MR, Wilhelm J, et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 2010;397:1225-33.
5. Glennon RA, Yousif MY, Naiman N, et al. Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 1987;26:547-51. (Pubitemid 17047729)
6. Kalix P. Cathinone, a natural amphetamine. Pharmacol Toxicol 1992;70:77-86.
7. Widler P, Mathys K, Brenneisen R, et al. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 1994;55:556-62. (Pubitemid 24192241)
8. Cozzi NV, Sievert MK, Shulgin AT, et al. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 1999;381:63-9. (Pubitemid 29488590)
9. Dal Casona TA, Young R, Glenon RA. Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogues. Pharmacol Biochem Behav 1997;58:1109-16. (Pubitemid 28108223)
10. Gustaffsson D, Escher C. Mefedron - Internetdrog som tycks ha kommit fo¨r att stanna. (Mephedrone - Internet drug that seems to have come to stay). La¨kartidningen 2009;106:2769-71.
11. Bateman DN, Good AM, Laing WJ, et al. TOXBASE: Poisons information on the internet. Emerg Med J 2002;19:31-4. (Pubitemid 34092534)
12. Adams RD, Lupton D, Good AM, et al. UK childhood exposures to pesticides 2004-2007: a TOXBASE toxicovigilance study. Arch Dis Child 2009;94:417-20.
13. Wood DM, Davies S, Puchnarewicz M, et al. Recreational use of 4- methylmethcathinone (4-MMC) presenting with sympathomimetic toxicity and confirmed by toxicological screening. Clin Toxicol 2009;47:733.
14. Mixmag. Mephedrone: meet the UK's favourite new drug. 2010. http://www. mixmag.net/mephedrone (accessed 23 Mar 2010).
15. Al-Motarreb A, Briancon S, Al-Jaber N, et al. Khat checwing is a risk factor for acute myocardial infarction: a case-control study. Br J Clin Pharmacol 2005;59:574-81. (Pubitemid 40632248)
16. Toennes SW, Harder S, Schramm M, et al. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol 2003;56:125-30. (Pubitemid 36886498)
17. Jo¨nsson LE, Anggård E, Gunne LM. Blockade of intravenous amphetamine euphoria in man. Clin Pharmacol Ther 1971;12:889-96.
18. Odenwald M, Neuner F, Schauer M, et al. Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Med 2005;3:5.
19. Cozzi NV, Foley KF. Methcathinone is a substrate for the serotonin uptake transporter. Pharmacol Toxicol 2003;93:219-25. (Pubitemid 37521958)
20. Sparago M, Wlos J, Yuan J, et al. Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. J Pharmacol Exp Ther 1996;279:1043-52. (Pubitemid 27166883)
21. Stepens A, Logina I, Liguts V, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008;358:1009-17. (Pubitemid 351347100)